nejm.org
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
Preapproval trials showed that messenger RNA (mRNA)–based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile, yet these trials were subject to s...